Attached to strands of DNA, they change shape, size, and chemistry to access diseased tissue, like a key fitting into a lock
Meet Deep Genomics, a privately-held company that seeks to harness the power of deep learning to transform medicine.
U of T experts suggest crystalized materials may hold wide commercial potential.
CURRENT ISSUE - October 2025
Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature